Cargando…
Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia
During the coronavirus disease 2019 (COVID-19) pandemic, patients with humoral immunodeficiency are at higher risk of developing chronic infection and having a negative outcome. Few data are available on therapeutic options for this population. This case report discusses the treatment of disease rel...
Autores principales: | Palomba, Emanuele, Carrabba, Maria, Zuglian, Gianluca, Alagna, Laura, Saltini, Paola, Fortina, Valeria, Hu, Cinzia, Bandera, Alessandra, Fabio, Giovanna, Gori, Andrea, Muscatello, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317455/ https://www.ncbi.nlm.nih.gov/pubmed/34332085 http://dx.doi.org/10.1016/j.ijid.2021.07.064 |
Ejemplares similares
-
Mucormycosis in CAPA, a Possible Fungal Super-Infection
por: Saltini, Paola, et al.
Publicado: (2021) -
Immune Checkpoint Inhibitors in People Living with HIV/AIDS: Facts and Controversies
por: Castelli, Valeria, et al.
Publicado: (2021) -
Nocardia Infections in the Immunocompromised Host: A Case Series and Literature Review
por: Palomba, Emanuele, et al.
Publicado: (2022) -
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
por: Ancona, Giuseppe, et al.
Publicado: (2023) -
Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation
por: Alagna, Laura, et al.
Publicado: (2020)